Aclarion Inc Ordinary Shares ACON
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ACON is a good fit for your portfolio.
News
-
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs
-
Aclarion Announces Closing of $3.0 Million Public Offering
-
Aclarion Announces Pricing of $3.0 Million Public Offering
-
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership
-
Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?
-
Thinking about buying stock in Panbela Therapeutics, Netflix, Qualcomm, Cyngn, or Aclarion?
-
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD
Trading Information
- Previous Close Price
- $0.30
- Day Range
- $0.28–0.30
- 52-Week Range
- $0.27–37.92
- Bid/Ask
- $0.28 / $0.31
- Market Cap
- $2.12 Mil
- Volume/Avg
- 52,895 / 959,533
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.03
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 6
- Website
- https://www.aclarion.com
Valuation
|
Metric
|
ACON
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.03 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ACON
|
|---|---|
Quick Ratio | 0.32 |
Current Ratio | 0.40 |
Interest Coverage | −7.07 |
Quick Ratio
ACON
Profitability
|
Metric
|
ACON
|
|---|---|
Return on Assets (Normalized) | −236.55% |
Return on Equity (Normalized) | −1,413.03% |
Return on Invested Capital (Normalized) | −594.81% |
Return on Assets
ACON
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Rbpnd | $38.8 Bil | |
VEEV
| Veeva Systems Inc Class A | Xddghmth | Wyv | $32.2 Bil | |
SOLV
| Solventum Corp | — | Hdbzw | $11.1 Bil | |
MTHRF
| M3 Inc | — | Rwfmrk | $8.3 Bil | |
MTHRY
| M3 Inc ADR | — | Ylvqblq | $8.3 Bil | |
HQY
| HealthEquity Inc | — | Cbvyqc | $6.9 Bil | |
PMCUF
| Pro Medicus Ltd | — | Pskdc | $6.9 Bil | |
RCM
| R1 RCM Inc | — | Qthzb | $5.1 Bil | |
DOCS
| Doximity Inc Class A | — | Lfgfk | $4.6 Bil | |
EVH
| Evolent Health Inc Class A | — | Yzpy | $3.5 Bil |